Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis

Endometriosis is a common, benign, and hormone-dependent gynaecological disorder that displays altered immunoinflammatory profiles. Myeloid-derived suppressor cells (MDSCs) suppressed immunosurveillance in endometriosis in human and mouse model. Receptor tyrosine kinase inhibitor Sunitinib can induc...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ying, Hung, Sze Wan, Liang, Bo, Zhang, Ruizhe, Gao, Yating, Chu, Ching Yan, Zhang, Tao, Xu, Hui, Chung, Jacqueline Pui Wah, Wang, Chi Chiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340010/
https://www.ncbi.nlm.nih.gov/pubmed/34367125
http://dx.doi.org/10.3389/fimmu.2021.641206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340010/
https://www.ncbi.nlm.nih.gov/pubmed/34367125
http://dx.doi.org/10.3389/fimmu.2021.641206

Ejemplares similares